AstraZeneca

With New Funding and CEO, This Southlake Biotech is Looking to Solve Kidney Disease

by | Feb 16, 2022
Renibus Therapeutics, which focuses on treatments for acute and chronic kidney diseases, announced closing a $35 million Series A funding round. Its new CEO, Frank Stonebanks, says "Renibus has arrived at a critical inflection point in its commitment to transform the prevention and treatment of kidney diseases."
MORE
With Americas HQ in Dallas, U.K.’s Brand Finance Releases 2022 Global 500 Rankings
by | Jan 27, 2022
Some insights: TikTok is the world's fastest-growing brand; tech is the most valuable industry at $1.3 trillion; retail continues to thrive with Walmart jumping up a spot; the pharma sector showed faster growth over the last two years than any other; and the U.S. and China continue to dominate. We spoke with the managing director of the company's Dallas Americas HQ about his firm's Texas business and plans for U.S. growth.
MORE
lung cancer
Giant Inflatable Lungs Will Give an Interactive Look at Lung Cancer During Fort Worth Visit
by | Nov 1, 2019
LungXperience features 14-foot-tall, 9-foot-wide inflatable lungs that visitors can walk through while carrying smart devices triggering a series of interactive modules.
MORE